期刊文献+

一例少见青少年T幼淋巴细胞白血病的病例报道及文献回顾

Diagnosis and Treatment of a Rare Adolescent T-cell Prolymphocytic Leukemia and Literature Review
原文传递
导出
摘要 目的:报道一例少见幼年幼淋巴细胞白血病(T-PLL)患者的病例资料及诊疗过程,并通过文献复习总结了T-PLL的临床特点和诊疗措施。方法:对病例资料进行对比分析,同时通过文献回顾研究T-PLL的特点及发生、发展及诊疗情况。结果:本病例为少见青少年型幼淋巴细胞白血病,细胞以成熟小淋巴细胞为主,特征免疫表型为CD7^+CD5^+CD4^+CD8^+CD3^+,无染色体异常,有TCR基因重排。结论:T-PLL病例具有多态性及复杂性,在临床诊断中需要密切联系临床特点及实验室诊断,综合判断疾病情况,做出最优治疗方案。 Objective: To reporte a rare type of adolescent of T-cell Prolymphocytic Leukemia(T-PLL), and summarize the clinical features and diagnostic measures of T-PLL through reviewing the literatures. Methods: The clinical data of a rare type of adolescent of T-PLL was analyzed. The characteristics, occurrence, development and diagnosis and treatment of T-PLL were studied through literature review. Results: This case is a rare juvenile lymphoblastic leukemia. Most of the cells are mature small lymphocyte.The characteristic immunophenotype is CD7^+CD5^+CD4^+CD8^+CD3^+. There is no chromosomal abnormality and TCR gene rearrangement positive. Conclusions: T-PLL has the characteristics of polymorphism and complexity. The clinical characteristics and laboratory diagnosis should be closely linked in clinical diagnosis, and disease conditions should be judged comprehensively to make the best treatment plan.
作者 常子维 李秋红 朱华锋 冯苗娟 苏小丽 侯丽萍 高山 于书春 田志强 赵亚萍 高广勋 CHANG Zi-wei;LI Qiu-hong;ZHU Hua-feng;FENG Miao-juan;SU Xiao-li;HOU Li-ping;GAO Shan;YU Shu-chun;TIAN Zhi-qiang;ZHAO Ya-ping;GAO Guang-xun(Department of hematology,XijingHospital,Air Force Military Medical University,Xi'an,Shaanxi,710032,China;Department of pediatrics,XijingHospital,Air Force Military Medical University,Xi'an,Shaanxi,710032,China)
出处 《现代生物医学进展》 CAS 2019年第20期3849-3852,3893,共5页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(30900639) 陕西省自然科学基金项目(2014JM2-8161) 吴阶平医学基金项目1项(320.6750.13276)
关键词 幼淋巴细胞白血病(T-PLL) 免疫表型 临床特点及实验室诊断 T-cell Prolymphocytic Leukemia(T-PLL) Immune phenotype Clinical characteristics and laboratory diagnosis
  • 相关文献

参考文献1

二级参考文献13

  • 1Dearden C. How I treat prolymphocytic leukemia. Blood, 2012, 120: 538-551.
  • 2Matures E. Novel and emerging drugs for rarer chronic lymphoid leukaemias. Curr Cancer Drug Targets, 2012, 12: 484-504.
  • 3Dungarwalla M, Mamtes E, Dearden CE. Prolymphocytic leukaemia of B- and T-cell subtype: a state-of-the-art paper. Eur J Haematol, 2008, 80: 469-476.
  • 4Matutes E, Brito-Babapulle V, Swansbury J, et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood, 1991,78: 3269-3274.
  • 5Hoyer JD, Ross CW, Li CY, et al. True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases. Blood, 1995, 86:1163-1169.
  • 6Kameoka J, Takahashi N, Noji H, et al. T-cell prolymphocytic leukemia in Japan: is it avariant?. Int J Hematol, 2012, 95: 660-667.
  • 7Takizawa M, Matsushima T, Yokohama A, et al. Unclassified mature T cell leukemia with cerebriform nuclei. Rinsho Ketsueki, 2005, 46:486-491.
  • 8Kussick S J, Wood BL, Sabath DE. Mature T cell leukemias which cannot be adequately classified under the new WHO classification of lymphoid neoplasms. Leukemia, 2002, 16: 2457-2458.
  • 9Matutes E, Catovsky D. Similarities between T-cell chronic lymphocytic leukemia and the small-cell variant of T- prolymphocytic leukemia. Blood, 1996, 87:3520-3521.
  • 10Matutes E, Catovsky D. Classification of mature T-cell leuke- mias. Leukemia, 2003,17:1682-1683.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部